ILD Co-morbidites, CVD and metabolic diseases

No definition available.

Summary Statistics

Key figures

All Female Male
Number of individuals 98348 45353 52995
Unadjusted prevalence (%) 37.82 30.86 46.87
Mean age at first event (years) 56.29 55.60 56.88

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 5.31 [4.96, 5.68] <1e-100 16861
15 years 0.03 6.62 [6.19, 7.08] <1e-100 13919
5 years 0.01 10.96 [10.01, 12.00] <1e-100 6174
1 year 0.00 26.02 [21.79, 31.06] <1e-100 2843

Correlations

Index endpoint: ILD_CVDMETABOCOMORB – ILD Co-morbidites, CVD and metabolic diseases
GWS hits:

Survival analyses between endpoints

Plot

before ILD Co-morbidites, CVD and metabolic diseases
after ILD Co-morbidites, CVD and metabolic diseases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after ILD Co-morbidites, CVD and metabolic diseases